Artigo de periodico

Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients (2022)

• Authors:
  • Pietrobon, Anna Julia
  • Andrejew, Roberta
  • Custodio, Ricardo Wesley Alberca
  • Oliveira, Luana de Mendonça
  • Scholl, Juliete Nathali
  • Teixeira, Franciane Mouradian Emidio
  • Brito, Cyro Alves de
  • Glaser, Talita
  • Kazmierski, Julia
  • Goffinet, Christine
  • Turdo, Anna Claudia
  • Yendo, Tatiana Mina
  • Aoki, Valeria
  • Figueiró, Fabrício
  • Battastini, Ana Maria
  • Ulrich, Henning
  • Benard, Gil
  • Duarte, Alberto José da Silva
  • Sato, Maria Notomi
• USP affiliated authors: AOKI, VALERIA - FM ; ULRICH, ALEXANDER HENNING - IQ ; BENARD, GIL - FM ; DUARTE, ALBERTO JOSE DA SILVA - FM ; SATO, MARIA NOTOMI - FM ; PIETROBON, ANNA JULIA - ICB ; CUSTODIO, RICARDO WESLEY ALBERCA - FM ; OLIVEIRA, LUANA DE MENDONÇA - FM ; TEIXEIRA, FRANCIANE MOURADIAN EMIDIO - ICB ; OLIVEIRA, LUANA DE MENDONÇA - ICB ; GLASER, TALITA - IQ ; YENDO, TATIANA MINA - FM
• Unidades: FM; IQ; ICB
• DOI: 10.3389/fimmu.2022.1012027
• Subjects: COVID-19; PURINAS; ADENOSINA
• Agências de fomento:
  • Financiamento Laboratory of Dermatology and Immunodeficiencies
  • Financiamento CAPES
  • Financiamento FAPESP
  • Financiamento CNPq
• Language: Inglês
• Imprenta:
  • Publisher place: Lausanne
  • Date published: 2022
• Source:
  • Título: Frontiers in Immunology
  • ISSN: 1664-3224
  • Volume/Número/Paginação/Ano: v. 13, p. 1-12 art. 1012027, 2022


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo publicado em periódico de acesso aberto (Gold Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	3107915.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  PIETROBON, Anna Julia et al. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Frontiers in Immunology, v. 13, p. 1-12 art. 1012027, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1012027. Acesso em: 01 abr. 2026.

• APA

  Pietrobon, A. J., Andrejew, R., Custodio, R. W. A., Oliveira, L. de M., Scholl, J. N., Teixeira, F. M. E., et al. (2022). Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Frontiers in Immunology, 13, 1-12 art. 1012027. doi:10.3389/fimmu.2022.1012027

• NLM

  Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira L de M, Scholl JN, Teixeira FME, Brito CA de, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo TM, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJ da S, Sato MN. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients [Internet]. Frontiers in Immunology. 2022 ; 13 1-12 art. 1012027.[citado 2026 abr. 01 ] Available from: https://doi.org/10.3389/fimmu.2022.1012027

• Vancouver

  Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira L de M, Scholl JN, Teixeira FME, Brito CA de, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo TM, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJ da S, Sato MN. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients [Internet]. Frontiers in Immunology. 2022 ; 13 1-12 art. 1012027.[citado 2026 abr. 01 ] Available from: https://doi.org/10.3389/fimmu.2022.1012027

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Efeito da suplementação materna com ácido retinoico durante a amamentação no sistema imunológico da prole de camundongos
• LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression
• The dysfunctional innate immune response triggered by toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus
• IgG from atopic dermatitis patients induces IL-17 and IL-10 production in infant intrathymic TCD4 and TCD8 cells
• Staphylococcal enterotoxins modulate the effector CD4(+)T cell response by reshaping the gene expression profile in adults with atopic dermatitis
• Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus
• Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+and CD33+CD11b+HLA-DR-CD14+CD66b-Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
• Eosinophilia in patients with atopic dermatitis is associated with increased expression of CCR3 and decreased expression of CD23 and CD62L
• Evidence of regulatory myeloid dendritic cells and circulating inflammatory epidermal dendritic cells-like modulated by Toll-like receptors 2 and 7/8 in adults with atopic dermatitis
• Recurrent and disseminated pityriasis versicolor: a novel clinical form consequent to Malassezia-host interaction?